Indian Army Pharmaceutical Procurement: Essential Medications Supply

Work Description - NA

This tender is issued by the Department of Military Affairs, Ministry of Defence, for the procurement of a comprehensive range of pharmaceutical products required by the Indian Army. The bid, identified by Bid Number GEM/2026/B/7950159, is scheduled to commence on September 3, 2026, at 12:01 PM and will conclude on September 24, 2026, at 12:00 PM. The procurement encompasses a significant total quantity of 3,370,890 units, covering a diverse array of medications. Specifically, the essential items include Divalproex Sodium CR 500 mg Tablets, Hydrochlorothiazide 25mg Tablets, Ropinirole in 0.5mg and 2mg tablet strengths, Sildenafil Citrate 50mg Tablets, Topiramate 25mg Tablets, Calamine lotion in 100ml bottles, Duloxetine 30mg Tablets, Clopidogrel 75 mg plus Aspirin 75 mg Tablets, Desvenlafaxine 50mg Tablets, Vitamin B complex tablets (with minimum concentrations of Vit B1 5mg, Vit B6 3mg, and Vit B12 5mcg), and a multi-vitamin and mineral supplement tablet containing Biotin 10mg, Iron 8mg, L-cysteine 5mg, Manganese 5mg, Copper, Selenium, L-lysine 20mg, Zinc 25mg, Dimethionine 40mg, Calcium Pantothenate 50mg, and Niacinamide 50mg. Additionally, the tender includes Brivaracetam 100 mg Tablets and Telmisartan 40mg Tablets. Interested bidders are invited to submit their proposals for the supply of these vital pharmaceutical products to support the healthcare needs of the Indian Army.